Clinical trials
Recruiting Phase 1/2 Amyotrophic Lateral Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ashvattha Therapeutics, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Biogipuzkoa Health Research Institute | 1 |
| Duke University | 1 |
| Leal Therapeutics, Inc | 1 |
| Nura Bio | 1 |
| Regeneron Pharmaceuticals | 1 |
| Talengen Institute of Life Sciences, Shenzhen, P.R. China. | 1 |
| Trace Neuroscience, Inc. | 1 |
| Vector Y Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyotrophic Lateral Sclerosis | 11 |
| Alzheimer Disease | 1 |
| Inflammation | 1 |
| Multiple Sclerosis | 1 |
| Neurodegenerative Diseases | 1 |
| Neuroinflammatory Diseases | 1 |
| Parkinson Disease | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.